Global Needle-Free Injection System Market Revenue, Demand, Opportunity, Segment and Key Trends 2019
The Global Needle-Free Injection System Market is projected to reach the US $20.17 billion, at a CAGR of 15.5% during the forecast period.
(businesspress24) - Growth in this Needle-Free Injection System Market is mainly driven by the growing prevalence of chronic disease, increasing the incidence of communicable disease due to needlestick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.
On the other hand, the high development cost of Needle-Free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
Download PDF (Needle-Free Injection System Market):
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced Needle Free injection solutions in the market. These strategies help market players to strengthen their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the Global Needle-Free Injection System Market.
The jet-based Needle-Free injectors are expected to witness the highest growth during the forecast period
Needle-Free Injection System Market segmentation:
· based on the product.
· based on technology.
· based on type.
· based on site of delivery.
· based on applications
· based on end-user
· based on regions.
Speak to Our Subject Expert (Needle-Free Injection System Market):
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=165815861
The high growth in this Needle-Free Injection System Market is attributed to the rising demand for biologics, the growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of the new injection system are key factors driving the market growth.
The Major Players Operating in the Needle-Free Injection System Market:
The needle-free injection system market is a fragmented market, with several big and emerging players. Key market players include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
Geographical Detailed Analysis for Needle-Free Injection System Market:
North America is expected to dominate the market, followed by Europe.
The Needle-Free injection system market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further sub-segmented into the U.S. and Canada; while Europe is further sub-segmented into Germany, France, the U.K. Italy, Spain, and Rest of Europe (RoE); Asia is further sub-segmented into Japan, China, India and Rest of Asia (RoA).
Request free research Sample pages (Needle-Free Injection System Market):
https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861
Themen in dieser Pressemitteilung:
needle
free-injection-system
needle
free-injection-system-market
needle
free-injection-system-market-size
needle
free-injection-system-market-share
needle
free-injection-system-market-research
needle
free-injection-system-market-growth
needle
free
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarketsâ„¢ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarketsâ„¢ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 27.03.2019 - 05:39 Uhr
Sprache: Deutsch
News-ID 1532831
Anzahl Zeichen: 3677
Kontakt-Informationen:
Ansprechpartner: shelly singh
Stadt:
northbrook
Telefon: 18886006441
Kategorie:
Marketing & Werbung
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 27.03.2019
Diese Pressemitteilung wurde bisher 115 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Needle-Free Injection System Market Revenue, Demand, Opportunity, Segment and Key Trends 2019 "
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
